Glucagon-like peptide-1 receptor agonists as potential preventive and therapeutic agents in ischemic stroke 1 Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 2 Department of Surgery, Division of Anatomy, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 3 Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada 4 Banting and Best Diabetes Centre, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada Advanced Neurology 2026 , 5(2), 025150027 Received: 7 April 2025 | Revised: 13 July 2025 | Accepted: 22 July 2025 | Published online: 11 September 2025 Stroke remains a significant contributor to mortality and morbidity worldwide, imposing a significant socioeconomic burden and underscoring the urgent need for both preventative and therapeutic strategies

References Compliance Notice This product is intended for laboratory research use only and is not approved for human or veterinary use.
How do I switch from semaglutide to tirzepatide
One vial 5 mg was $55 now $40 BPC-157 5mg is a synthetic pentadecapeptide available for research use from GenoScience
Sex hormones can influence the rhythm of the heart in very distinct ways